Inhibition of the autophagy-related protein PIK3C3/VPS34 in melanoma recruits NK and CD8+T cells into the tumor bed, and as such improves the efficacy of anti-PD-1/PD-L1 immunotherapy. Here, PDCD1 is linked to melanoma.